About this episode
The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.
Comments
Rate this episode
Episode Details
- Author
- Spencer Diamond Principal Investigator Innovative Genomics Institute at UC Berkeley, Christopher Reyes CEO Founder Director Bloom Science, Eric Shaff President & CEO Seres Therapeutics
- Show Type
- full
- Audio Format
- audio/mpeg